ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 77 filers reported holding ACELRX PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 2.61 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $12,000 | -42.9% | 41,000 | 0.0% | 0.00% | -33.3% |
| Q4 2021 | $21,000 | -22.2% | 41,000 | +57.7% | 0.01% | -25.0% |
| Q3 2021 | $27,000 | -52.6% | 26,000 | -36.6% | 0.01% | -55.6% |
| Q2 2021 | $57,000 | -18.6% | 41,000 | 0.0% | 0.02% | -21.7% |
| Q1 2021 | $70,000 | -21.3% | 41,000 | 0.0% | 0.02% | -23.3% |
| Q4 2020 | $89,000 | -12.7% | 41,000 | -43.1% | 0.03% | +42.9% |
| Q3 2020 | $102,000 | +64.5% | 72,000 | +38.5% | 0.02% | +61.5% |
| Q2 2020 | $62,000 | – | 52,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 12,528,120 | $38,210,000 | 1.53% |
| Cormorant Asset Management, LP | 850,000 | $2,593,000 | 0.41% |
| Palo Alto Investors LP | 1,656,644 | $5,053,000 | 0.24% |
| Granahan Investment Management | 1,745,604 | $5,324,000 | 0.16% |
| Spark Investment Management LLC | 318,500 | $980,000 | 0.13% |
| Opus Point Partners Management, LLC | 57,747 | $176,000 | 0.10% |
| SHEPHERD KAPLAN KROCHUK, LLC | 76,472 | $233,000 | 0.06% |
| Joel Isaacson & Co., LLC | 70,660 | $216,000 | 0.06% |
| MYCIO WEALTH PARTNERS, LLC | 75,000 | $229,000 | 0.05% |
| Cornerstone Capital, Inc. | 59,200 | $181,000 | 0.04% |